Frendl D - Search Results

1

Primary care physician's (PCP) perceived value of patient-reported outcomes (PROs) in clinical practice: a mixed methods study.

Mou D, Horn DM, Heng M, Castillo-Angeles M, Ladin K, Frendl D, Kaur M, Del Carmen M, Sequist TD, Sisodia RC. Mou D, et al. Among authors: frendl d. BMJ Qual Saf. 2022 Mar;31(3):221-229. doi: 10.1136/bmjqs-2020-012206. Epub 2021 May 20. BMJ Qual Saf. 2022. PMID: 34016689

2

Hospital at Home for Surgical Patients: A Case Series From a Pioneer Program at a Large Academic Medical Center.

Safavi KC, Frendl D, Ellis D, Sisodia RC, Ricciardi R, McGovern FJ, Ferris TG, Thompson RW, Del Carmen MG. Safavi KC, et al. Among authors: frendl d. Ann Surg. 2022 Jan 1;275(1):e275-e277. doi: 10.1097/SLA.0000000000005074. Ann Surg. 2022. PMID: 34914664 No abstract available.

3

Impact of 2012 USPSTF Screening PSA Guideline Statement: Changes in Primary Care Provider Practice Patterns and Attitudes.

Miller A, Yates J, Epstein MM, Fantasia J, Frendl D, Afiadata A, Sokoloff M, Luckmann R. Miller A, et al. Among authors: frendl d. Urol Pract. 2017 Mar;4(2):126-131. doi: 10.1016/j.urpr.2016.04.003. Epub 2016 Oct 6. Urol Pract. 2017. PMID: 37592666

4

Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool.

Frendl DM, FitzGerald G, Epstein MM, Allison JJ, Sokoloff MH, Ware JE. Frendl DM, et al. PLoS One. 2020 Dec 7;15(12):e0240039. doi: 10.1371/journal.pone.0240039. eCollection 2020. PLoS One. 2020. PMID: 33284845 Free PMC article.

5

Understanding temporal trends in medical costs associated with progression to metastatic prostate cancer.

Frendl DM, Olumi AF. Frendl DM, et al. Cancer. 2017 Sep 15;123(18):3447-3449. doi: 10.1002/cncr.30779. Epub 2017 May 23. Cancer. 2017. PMID: 28542736 Free article. No abstract available.

6

Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey.

Frendl DM, Ware JE Jr. Frendl DM, et al. Med Care. 2014 May;52(5):439-45. doi: 10.1097/MLR.000000000000010311. Med Care. 2014. PMID: 24714581 Review.

7

Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancer.

Frendl DM, Sokoloff MH. Frendl DM, et al. Med Care. 2014 Jul;52(7):576-8. doi: 10.1097/MLR.0000000000000173. Med Care. 2014. PMID: 24926703 No abstract available.

8

Assessing health-related quality of life in patients with benign non-toxic goitre.

Watt T, Cramon P, Frendl DM, Ware JE Jr; ThyQoL Group. Watt T, et al. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):559-75. doi: 10.1016/j.beem.2014.01.009. Epub 2014 Jan 28. Best Pract Res Clin Endocrinol Metab. 2014. PMID: 25047206 Review.

9

Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.

Frendl DM, Epstein MM, Fouayzi H, Krajenta R, Rybicki BA, Sokoloff MH. Frendl DM, et al. Cancer Causes Control. 2020 Sep;31(9):861-867. doi: 10.1007/s10552-020-01324-x. Epub 2020 Jun 17. Cancer Causes Control. 2020. PMID: 32556947 Free PMC article.

10

High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.

Zhang H, Frendl DM, Wang Z, Olumi AF. Zhang H, et al. J Urol. 2020 Aug;204(2):325-331. doi: 10.1097/JU.0000000000001014. Epub 2020 Mar 13. J Urol. 2020. PMID: 32167867 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters